PROM1 and hepatocellular carcinoma: In our previous study, we identified CD133 as a CSC surface marker through characterization of CSCs in primary HCC and found CD133+ primary HCC cells displayed greater tumor spheroid-forming ability and chemoresistance than CD133− primary HCC cells [8].